Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BPTS - Biophytis - ADR

IEX Last Trade
1.555
0.005   0.322%

Share volume: 9,355,362
Last Updated: Tue 08 Aug 2023 09:56:35 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1.55
0.01
0.32%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-40.78%
6 Months
-67.88%
1 Year
-90.53%
2 Year
-97.99%
Key data
Stock price
$1.56
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$8.01 - $141.20
52 WEEK CHANGE
-$0.91
MARKET CAP 
4.319 M
YIELD 
N/A
SHARES OUTSTANDING 
525.425 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Stanislas Veillet
Region: US
Website: https://www.biophytis.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

biophytis is a biotech company developping therapeutics for aging diseases. it that has been created in 2006 as a spin-off of université pierre et marie curie (paris). biophytis has developped a portfolio of drug candidates at clinical stage for the treatment of sarcopenic obesity (bio101, bio103) and dry age-related macular degeneration (bio201).

Recent news